Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
J Clin Virol ; 104: 11-15, 2018 07.
Article in English | MEDLINE | ID: mdl-29704733

ABSTRACT

BACKGROUND: Most laboratories use RSV PCR but near-patient tests (NPT) performed at paediatric clinics are believed to be increasingly used. Anonymised data on RSV infections has been collected since 1990 in Sweden. No evaluation of Swedish RSV surveillance or use of laboratory testing had previously been performed. OBJECTIVES: Swedish RSV data and methods used for RSV laboratory testing and reporting were evaluated in order to improve RSV surveillance in a forthcoming vaccine era. STUDY DESIGN: RSV data obtained in Sweden 2015-2016 were reviewed. Data on methods used for the RSV laboratory detection and reporting were collected via on-line questionnaires submitted to laboratories (n = 26) and clinics (n = 4) known to perform virological testing. Swedish Quality Control Program reports from 2013 to 2015 on the performance of RSV testing were also evaluated. RESULTS: Over 60% of RSV infections were diagnosed in children under 5 years (1917/2925), but infections were also common in those 65 years and older (n = 607). Two laboratories limited RSV testing to children only. RSV NPT was utilised in eight clinics; four participated in RSV surveillance. RSV NPTs evaluated could only detect 50% of RSV positive samples. Reporting was complete and timely, but took too much time (18 min/week/laboratory). CONCLUSIONS: Although most common in children, RSV infections are also common in the elderly, and testing should not be limited to children only. The poor performance of RSV NPT and importance of confirming results should be communicated to all relevant laboratories and clinics. All clinics should be encouraged to participate in surveillance. Automated case-based reporting should be considered.


Subject(s)
Clinical Laboratory Techniques/methods , Epidemiological Monitoring , Health Services Research , Respiratory Syncytial Virus Infections/diagnosis , Respiratory Syncytial Viruses/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Disease Notification/methods , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Point-of-Care Testing , Surveys and Questionnaires , Sweden , Young Adult
2.
Infect Dis (Lond) ; 50(5): 361-371, 2018 05.
Article in English | MEDLINE | ID: mdl-29260605

ABSTRACT

BACKGROUND: Few prospective cohort studies have estimated the overall impact of severe rotavirus gastroenteritis (RVGE) leading to hospitalization on families and society. We assessed human and economic resources needed to care for an affected average child aged <5 years in Sweden. METHODS: The study was conducted in Astrid Lindgren Children's Hospital which serves approximately 14% of all Swedish children <5 years of age. All children admitted with acute gastroenteritis in the study period were tested for rotavirus. Health care consumption was collected prospectively and publically available unit costs used to calculate direct costs. Non-medical and indirect costs were collected in interviews with families using a standardized questionnaire during the hospital stay and approximately 14 days post-discharge. RESULTS: 144/206 children (70%) with laboratory-confirmed RVGE were included. The median age was 14 months. The average total cost per hospitalized child was €3894, of which €2169 (56%) was due to direct healthcare-related costs (including Emergency Department visits and in-patient care), €104 (2%) to non-medical direct costs and €1621 (42%) to indirect costs due to productivity loss. Carers of children with severe RVGE were absent from work on average five days per study child: four days during hospitalization of affected child and one day due to gastroenteritis in the carer. CONCLUSIONS: Costs for RVGE are dominated by direct costs which are similar to some other countries in Europe, but indirect costs due to productivity loss are also important, and should be considered in decisions to introduce rotavirus vaccines into national vaccination programmes.


Subject(s)
Family/psychology , Gastroenteritis/epidemiology , Rotavirus Infections/economics , Rotavirus Infections/epidemiology , Rotavirus/isolation & purification , Acute Disease/epidemiology , Child, Preschool , Cohort Studies , Emergency Service, Hospital , Family/ethnology , Female , Gastroenteritis/economics , Gastroenteritis/virology , Hospitalization/economics , Hospitalization/statistics & numerical data , Humans , Infant , Male , Prospective Studies , Rotavirus Infections/ethnology , Rotavirus Infections/virology , Rotavirus Vaccines , Surveys and Questionnaires , Sweden/epidemiology , Vaccination
3.
Infect Ecol Epidemiol ; 6: 31079, 2016.
Article in English | MEDLINE | ID: mdl-27059819

ABSTRACT

BACKGROUND: Campylobacter jejuni is among the most frequent causes of bacterial gastroenteritis in Europe. Over 8,000 C. jejuni multilocus sequence typing sequence types (STs) have been described; ST-21 and ST-45 have been identified as the most frequent types in all human studies so far. In contrast to other STs, ST-22 has been associated with the Guillain-Barré syndrome and ST-677 was recently linked to severe systemic infections in Finland. We investigated risk factors associated with hospitalisation in individuals with C. jejuni infections acquired in Sweden. METHODS: A total of 1,075 individuals with domestically acquired C. jejuni infection diagnosed between November 2011 and October 2012 in Sweden were included in this retrospective cohort study. Typing data for the isolates as well as clinical data including hospitalisation dates and diagnosis codes for individuals with C. jejuni infection were obtained. Factors associated with hospitalisation and length of hospitalisation were investigated by multivariable analysis. RESULTS: A total of 289 individuals were hospitalised due to C. jejuni infection (26.8%); those with co-morbidities were over 14 times more likely to become hospitalised than those without (odds ratio [OR]: 14.39, 95% confidence interval [CI]: 6.84-30.26). Those with underlying co-morbidities were also hospitalised longer than those without (4.22 days vs. 2.86 days), although this was not statistically significant. C. jejuni ST-257 (OR: 2.38; CI: 1.08-5.23), but not ST-22 or ST-677, was significantly associated with hospitalisation. CONCLUSION: ST-677 was not associated with increased hospitalisation or a longer hospital stay in our study whilst ST-257 was. However, individuals with C. jejuni infections were generally more frequently hospitalised than previously demonstrated; this requires further consideration including possible targeted interventions.

4.
Infect Dis (Lond) ; 48(2): 93-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26414596

ABSTRACT

In 2014 the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy (RAV) conducted a review and analysis of the state of knowledge on the duration of follow-up after exposure to human immunodeficiency virus (HIV). Up until then a follow-up of 12 weeks after exposure had been recommended, but improved tests and new information on early diagnosis motivated a re-evaluation of the national recommendations by experts representing infectious diseases and microbiology, county medical officers, the RAV, the Public Health Agency, and other national authorities. Based on the current state of knowledge the Public Health Agency of Sweden and the RAV recommend, starting in April 2015, a follow-up period of 6 weeks after possible HIV-1 exposure, if HIV testing is performed using laboratory-based combination tests detecting both HIV antibody and antigen. If point-of-care rapid HIV tests are used, a follow-up period of 8 weeks is recommended, because currently available rapid tests have insufficient sensitivity for detection of HIV-1 antigen. A follow-up period of 12 weeks is recommended after a possible exposure for HIV-2, since presently used assays do not include HIV-2 antigens and only limited information is available on the development of HIV antibodies during early HIV-2 infection. If pre- or post-exposure prophylaxis is administered, the follow-up period is recommended to begin after completion of prophylaxis. Even if infection cannot be reliably excluded before the end of the recommended follow-up period, HIV testing should be performed at first contact for persons who seek such testing.


Subject(s)
Anti-HIV Agents/administration & dosage , HIV Antibodies/blood , HIV Antigens/blood , HIV Infections/diagnosis , HIV Infections/prevention & control , Post-Exposure Prophylaxis/methods , Serologic Tests/methods , Chemoprevention/methods , Early Diagnosis , HIV Infections/virology , HIV-1/isolation & purification , HIV-2/isolation & purification , Health Personnel , Humans , Occupational Exposure , Sweden , Time Factors
5.
J Infect Dis ; 213(4): 592-9, 2016 Feb 15.
Article in English | MEDLINE | ID: mdl-26347574

ABSTRACT

INTRODUCTION: It is increasingly difficult to differentiate measles viruses (MeVs) relating to certain outbreaks on the basis of the nucleoprotein (N) gene sequence only, as the diversity of circulating MeV strains has decreased. We studied genomic regions that could provide better molecular discrimination between epidemiologically linked and unlinked MeV variants identified in Sweden during 2013-2014. METHODS: The hemagglutinin (H) gene and hypervariable region between the fusion and matrix genes (MF-HVR) from 53 MeV-positive samples were amplified and sequenced. Data on phylogenetic clustering of MeVs on the basis of N, H, and MF-HVR sequences were compared to epidemiological data. RESULTS: MeVs were genotyped: 27 were B3, and 26 were D8. One genotype B3 cluster based on the N gene sequence contained epidemiologically unrelated viruses from 4 outbreaks, whereas analysis of H and MF-HVR sequences separated them into phylogenetic clusters consistent with the epidemiological data. Similarly, the single cluster of viruses with a genotype D8 N gene could be divided into the 5 outbreak groups on the basis of the phylogeny of MF-HVR sequences. CONCLUSIONS: A detailed picture of MeV circulation with more-defined links between outbreaks was obtained by sequencing the H gene and MF-HVR. Further identification and better genetic characterization of MeVs internationally is essential in identifying sources and routes of MeV spread within and beyond Europe in the elimination end game.


Subject(s)
Disease Outbreaks , Hemagglutinins, Viral/genetics , Measles virus/classification , Measles virus/genetics , Measles/epidemiology , Measles/virology , Sequence Analysis, DNA , Child , Cluster Analysis , Female , Genetic Variation , Genotype , Humans , Infant , Male , Measles virus/isolation & purification , Middle Aged , Molecular Epidemiology , Nucleocapsid Proteins , Nucleoproteins/genetics , Phylogeny , Sequence Homology , Sweden/epidemiology , Viral Fusion Proteins/genetics , Viral Proteins/genetics
6.
Scand J Infect Dis ; 46(10): 673-7, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25073537

ABSTRACT

The modern medical treatment of HIV with antiretroviral therapy (ART) has drastically reduced the morbidity and mortality in patients infected with this virus. ART has also been shown to reduce the transmission risk from individual patients as well as the spread of the infection at the population level. This position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy is based on a workshop organized in the fall of 2012. It summarizes the latest research and knowledge on the risk of HIV transmission from patients on ART, with a focus on the risk of sexual transmission. The risk of transmission via shared injection equipment among intravenous drug users is also examined, as is the risk of mother-to-child transmission. Based on current knowledge, the risk of transmission through vaginal or anal intercourse involving the use of a condom has been judged to be minimal, provided that the person infected with HIV fulfils the criteria for effective ART. This probably also applies to unprotected intercourse, provided that no other sexually transmitted infections are present, although it is not currently possible to fully support this conclusion with direct scientific evidence. ART is judged to markedly reduce the risk of blood-borne transmission between people who share injection equipment. Finally, the risk of transmission from mother to child is very low, provided that ART is started well in advance of delivery.


Subject(s)
Anti-Retroviral Agents/therapeutic use , Antiretroviral Therapy, Highly Active/methods , Disease Transmission, Infectious , HIV Infections/drug therapy , HIV Infections/transmission , Infectious Disease Transmission, Vertical , Humans , Risk Assessment , Sweden
7.
Scand J Infect Dis ; 46(4): 294-302, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24484415

ABSTRACT

BACKGROUND: The aim of this prospective cohort study was to estimate the burden of severe disease caused by rotavirus-induced gastroenteritis in Swedish children aged < 5 y. METHODS: Rotavirus-positive children admitted to hospitals serving 3 geographical regions with 155,838 children aged < 5 y, were offered inclusion in this 1-year study. Rotavirus strains identified were genotyped using multiplex PCR. Disease progression was documented through interviews and chart reviews. RESULTS: In total, 604 children with rotavirus-induced gastroenteritis were included in the study. Forty-nine of 604 (8.1%) fulfilled the criteria for nosocomial infection. The minimum incidence was 388 per 100,000, with significant variability between study regions, ranging from 280 to 542 per 100,000. In all regions, the peak season occurred in February-April, but the season start varied, with first cases observed in October in the eastern region and December in the northern region. Genotypes identified differed between the regions: G1[P8] was most prevalent in all regions (77%), while the most varied pattern was observed in the western region, with G1[P8] observed in 61%, G4[P8] in 13%, G9[P8] in 10%, G2[P4] in 8%, and G3[P8] in 8% of the children. The median age of hospitalized children was 14 months and the median total duration of diarrhoea was 6.9 days. Sixty-eight percent reported a temperature > 38.5°C upon admission. Complications occurred in > 10% of the children, with hypertonic dehydration (32/604) and seizures (10/604) occurring most frequently. CONCLUSIONS: Rotaviruses may cause severe febrile acute gastroenteritis leading to dehydration requiring acute rehydration in hospital. In addition, further complications occurred in > 10% of hospitalized children.


Subject(s)
Gastroenteritis/epidemiology , Gastroenteritis/virology , Rotavirus Infections/epidemiology , Rotavirus Infections/virology , Child, Preschool , Community-Acquired Infections/epidemiology , Community-Acquired Infections/virology , Cross Infection/epidemiology , Cross Infection/virology , Female , Hospitalization/statistics & numerical data , Humans , Incidence , Infant , Infant, Newborn , Male , Prospective Studies , Rotavirus/genetics , Rotavirus/isolation & purification , Sweden/epidemiology
8.
BMC Immunol ; 13: 1, 2012 Jan 04.
Article in English | MEDLINE | ID: mdl-22217111

ABSTRACT

BACKGROUND: Experimental studies in humans have yielded evidence that adaptive immune function, including the production of antigen-specific antibodies, is distinctly impaired when sleep is deprived at the time of first antigen exposure. Here we examined the effects of a regular 24-hour sleep-wake cycle (including 8 hours of nocturnal sleep) and a 24-hour period of continuous wakefulness on the 7-week antibody production in 11 males and 13 females in response to the H1N1 (swine flu) virus vaccination. The specific antibody titer in serum was assayed by the hemagglutination inhibition test on the days 5, 10, 17, and 52 following vaccination. RESULTS: In comparison to the sleep group, sleep-deprived males but not females had reduced serum concentration of H1N1-specific antibodies five days after vaccination, whereas antibody titers at later time points did not differ between the conditions. CONCLUSIONS: These findings concur with the notion that sleep is a supportive influence in the very early stage of an adaptive immune response to a viral antigen. However, our results do not support the view that acute sleep deprivation has lasting effects on the human antibody titer response to influenza vaccination.


Subject(s)
Antibodies, Viral/immunology , Antibody Formation/immunology , Influenza A Virus, H1N1 Subtype/immunology , Influenza Vaccines/immunology , Sleep Deprivation/immunology , Female , Hemagglutination Inhibition Tests , Humans , Male , Sleep/immunology , Sleep Deprivation/physiopathology , Titrimetry , Vaccination , Young Adult
9.
PLoS One ; 7(12): e53511, 2012.
Article in English | MEDLINE | ID: mdl-23285299

ABSTRACT

The immunity to pandemic influenza A(H1N1)pdm09 in Sweden before and after the outbreaks in 2009 and 2010 was investigated in a seroepidemiological study. Serum samples were collected at four time points: during 2007 (n = 1968), in October 2009 (n = 2218), in May 2010 (n = 2638) and in May 2011 (n = 2513) and were tested for hemagglutination inhibition (HI) antibodies. In 2007, 4.9% of the population had pre-existing HI titres ≥40, with the highest prevalence (20.0%) in 15-24 year-olds, followed by ≥80 year-olds (9.3%). The overall prevalence of HI titres ≥40 had not changed significantly in October 2009. In May 2010 the prevalence had increased to 48.6% with the highest percentages in 5-14 year-olds (76.2%) andlowest in 75-79 year-olds (18.3%). One year later the prevalence of HI titres ≥40 had increased further to 52.2%. Children 5-14 years had the highest incidence of infection and vaccine uptake as well as the highest post-pandemic protective antibody levels. In contrast, the elderly had high vaccine uptake and low attack rate but low levels of protective antibodies, underlining that factors other than HI antibodies are involved in protection against influenza A(H1N1)pdm09. However, for all age-groups the seroprevalence was stable or increasing between 2010 and 2011, indicating that both vaccine- and infection-induced antibodies were long-lived.


Subject(s)
Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/epidemiology , Mass Vaccination , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Influenza, Human/blood , Influenza, Human/immunology , Male , Middle Aged , Pandemics/statistics & numerical data , Seroepidemiologic Studies , Sweden/epidemiology , Young Adult
10.
Scand J Infect Dis ; 42(9): 679-86, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20507261

ABSTRACT

To study influenza virus shedding during acute infection, viral load was longitudinally measured by quantitative PCR in nasal flocked swabs from patients with seasonal H3N2 influenza at a Swedish emergency department, including both hospitalized patients and outpatients. Influenza A was detected in 65/184 patients. Sampling was repeated every 3-4 days in 45 patients, with the aim of continuing sampling until day 12 after disease onset. Home visits were offered. Antibodies were measured on paired sera in 95/184 patients. Fifty percent of the patients remained polymerase chain reaction (PCR)-positive 8 days after disease onset in a Kaplan-Meier survival curve. The longest observed duration of viral shedding was 12 days. The average viral load was initially low, peaked on days 2-3 of disease and then declined. Viral decline results remained similar when all 15 (25%) oseltamivir-treated patients were excluded. Significant antibody titre changes were seen in all the 35 PCR verified cases with available paired sera and in 8 of the 58 patients with negative PCR tests on acute phase nasal samples. In conclusion, quantitative PCR testing indicated the presence of influenza virus for up to 12 days, which could have implications for disease transmission and infection control.


Subject(s)
Influenza A Virus, H3N2 Subtype/genetics , Influenza, Human/virology , RNA, Viral/analysis , Adolescent , Adult , Aged , Aged, 80 and over , Emergency Service, Hospital , Female , Follow-Up Studies , Humans , Influenza, Human/transmission , Kaplan-Meier Estimate , Male , Middle Aged , Nasal Cavity/virology , Outpatients , Polymerase Chain Reaction/methods , Regression Analysis , Sweden , Viral Load , Virus Shedding
11.
J Clin Microbiol ; 47(8): 2411-8, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19494060

ABSTRACT

A total of 101 food-borne and waterborne outbreaks that were caused by norovirus and that resulted in more than 4,100 cases of illness were reported to the Swedish Institute for Infectious Disease Control from January 2002 to December 2006. Sequence and epidemiological data for isolates from 73 outbreaks were analyzed. In contrast to health care-related outbreaks, no clear seasonality could be observed. Sequence analysis showed a high degree of genetic variation among the noroviruses detected. Genogroup II (GII) viruses were detected in 70% of the outbreaks, and of those strains, strains of GII.4 were the most prevalent and were detected in 25% of all outbreaks. The GII.4 variants detected in global outbreaks in health care settings during 2002, 2004, and 2006 were also found in the food-borne outbreaks. GI strains totally dominated as the cause of water-related (drinking and recreational water) outbreaks and were found in 12 of 13 outbreaks. In 14 outbreaks, there were discrepancies among the polymerase and capsid genotype results. In four outbreaks, the polymerase of the recombinant GII.b virus occurred together with the GII.1 or GII.3 capsids, while the GII.7 polymerase occurred together with the GII.6 and GII.7 capsids. Mixed infections were observed in six outbreaks; four of these were due to contaminated water, and two were due to imported frozen berries. Contaminated food and water serve as important reservoirs for noroviruses. The high degree of genetic diversity found among norovirus strains causing food-borne and waterborne infections stresses the importance of the use of broad reaction detection methods when such outbreaks are investigated.


Subject(s)
Caliciviridae Infections/epidemiology , Disease Outbreaks , Gastroenteritis/epidemiology , Gastroenteritis/virology , Genetic Variation , Norovirus/classification , Norovirus/genetics , Caliciviridae Infections/virology , Food Microbiology , Genotype , Humans , Molecular Epidemiology , Molecular Sequence Data , Norovirus/isolation & purification , Prevalence , RNA, Viral/genetics , Sequence Analysis, DNA , Sweden/epidemiology , Viral Proteins/genetics , Water Microbiology
12.
J Med Virol ; 81(8): 1432-7, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19551833

ABSTRACT

A quantitative polymerase chain reaction (PCR) assay was evaluated retrospectively on 92 cerebrospinal fluid (CSF) samples from 29 patients with herpes simplex virus (HSV) encephalitis with the aim to study if the concentration of HSV genomes can be used as a prognostic marker and for monitoring of antiviral therapy. The results were compared to those obtained previously by nested PCR, and the numbers of HSV genomes/ml were evaluated in correlation to patient outcome and treatment. The aims were to compare the sensitivity of a conventional nested PCR to a quantitative PCR, to investigate the range of HSV genome concentration in initial samples and to evaluate possible relationships between the HSV DNA concentrations in CSF, neopterin levels, and outcome of disease. The 29 initial samples contained between 2 x 10(2) and 42 x 10(6) HSV genomes/ml. There was no apparent correlation between the amount of HSV DNA in the initial samples and income status, initial neopterin levels, or prognosis. The number of HSV genomes/ml declined after treatment in all patients, but HSV DNA was still detectable after day 20 in 3 out of 16 patients. A long duration of genome detectability was found to correlate with poor outcome. There was no difference in sensitivity between the nested PCR and the quantitative PCR. While the quantitative PCR is more rational than a nested PCR, the quantitation of HSV genomes does not seem very useful as a prognostic marker in HSV encephalitis.


Subject(s)
Cerebrospinal Fluid/virology , DNA, Viral/cerebrospinal fluid , Encephalitis, Herpes Simplex/virology , Herpesvirus 1, Human/isolation & purification , Herpesvirus 2, Human/isolation & purification , Polymerase Chain Reaction/methods , Adolescent , Adult , Aged , Aged, 80 and over , Drug Monitoring , Female , Herpesvirus 1, Human/genetics , Herpesvirus 2, Human/genetics , Humans , Male , Middle Aged , Prognosis , Sensitivity and Specificity , Viral Load , Young Adult
13.
J Neurol ; 256(8): 1243-51, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19353228

ABSTRACT

Herpes simplex encephalitis is a devastating disease. In the early 1980s our group conducted a nationwide clinical trial of acyclovir versus vidarabine in patients with herpes simplex encephalitis in whom intrathecal herpes simplex virus (HSV) antibodies were assayed. The purpose of this study was to investigate if antibody levels and viral load correlate with outcome in herpes simplex encephalitis. We have analysed the prognostic value of HSV antibody levels in serum and cerebrospinal fluid (CSF) at the start of antiviral treatment in the 53 included patients. Frozen samples from a subset of patients were analysed with quantitative polymerase chain reaction (PCR) to assess the prognostic value of the viral load in CSF. IgG-levels in CSF at presentation were significantly higher in vidarabine-treated patients with a favourable outcome than in those treated with vidarabine but with an unfavourable outcome. The intrathecal viral load at presentation showed no correlation with outcome. However, the duration of positive HSV-PCR in CSF was longer in vidarabine-treated than in acyclovir-treated patients. These findings indicate that the B-cell response is important in the pathogenetic process of herpes simplex encephalitis. However, neither antibody levels nor viral load at presentation are useful as prognostic markers for the individual patient in this study.


Subject(s)
Antibodies, Viral/analysis , Encephalitis, Herpes Simplex/drug therapy , Viral Load , Acyclovir/pharmacology , Acyclovir/therapeutic use , Adolescent , Adult , Aged , Antibodies, Viral/blood , Antibodies, Viral/cerebrospinal fluid , Antibody Formation/immunology , Antiviral Agents/therapeutic use , B-Lymphocytes/immunology , B-Lymphocytes/virology , DNA, Viral/analysis , Encephalitis, Herpes Simplex/immunology , Encephalitis, Herpes Simplex/virology , Female , Humans , Immunoglobulin G/analysis , Immunoglobulin G/blood , Immunoglobulin G/cerebrospinal fluid , Male , Microbial Sensitivity Tests/methods , Middle Aged , Polymerase Chain Reaction/methods , Predictive Value of Tests , Prognosis , Time Factors , Treatment Outcome , Vidarabine/pharmacology , Vidarabine/therapeutic use , Young Adult
14.
Eur Neurol ; 61(5): 289-94, 2009.
Article in English | MEDLINE | ID: mdl-19295216

ABSTRACT

The aim of this study was to investigate the incidence of influenza-related encephalitis in Sweden during 11.5 years. Studies from Japan report an increased incidence of influenza-related encephalitis/encephalopathy. Few other studies are available. We conducted a retrospective register-based study on the Swedish National Inpatient Register, which covers all Swedish hospitals. In 1987-1998, a total number of 14,250 hospitalized individuals had an influenza diagnosis (population incidence: 137 per million person-years). In-hospital mortality was 4.1%. Using three different approaches, only 21 cases of influenza-related encephalitis were found, corresponding to a rate of 1.5 per 1,000 hospitalized persons with an influenza diagnosis (population incidence 0.21 per million person-years). We conclude that encephalitis following influenza occurs rarely, or is an infrequently recognized, diagnosed or reported complication. The cases we studied in detail have all recovered without sequels.


Subject(s)
Encephalitis, Viral/epidemiology , Encephalitis, Viral/etiology , Influenza, Human/complications , Influenza, Human/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Encephalitis, Viral/mortality , Female , Humans , Incidence , Influenza, Human/mortality , Male , Middle Aged , Registries , Sweden/epidemiology , Young Adult
15.
Virol J ; 5: 113, 2008 Oct 06.
Article in English | MEDLINE | ID: mdl-18837987

ABSTRACT

BACKGROUND: The analysis of the nonstructural (NS) gene of the highly pathogenic (HP) H5N1 avian influenza viruses (AIV) isolated in Sweden early 2006 indicated the co-circulation of two sub-lineages of these viruses at that time. In order to complete the information on their genetic features and relation to other HP H5N1 AIVs the seven additional genes of twelve Swedish isolates were amplified in full length, sequenced, and characterized. RESULTS: The presence of two sub-lineages of HP H5N1 AIVs in Sweden in 2006 was further confirmed by the phylogenetic analysis of approximately the 95% of the genome of twelve isolates that were selected on the base of differences in geographic location, timing and animal species of origin. Ten of the analyzed viruses belonged to sub-clade 2.2.2. and grouped together with German and Danish isolates, while two 2.2.1. sub-clade viruses formed a cluster with isolates of Egyptian, Italian, Slovenian, and Nigerian origin. The revealed amino acid differences between the two sub-groups of Swedish viruses affected the predicted antigenicity of the surface glycoproteins, haemagglutinin and neuraminidase, rather than the nucleoprotein, polymerase basic protein 2, and polymerase acidic protein, the main targets of the cellular immune responses. The distinctive characteristics between members of the two subgroups were identified and described. CONCLUSION: The comprehensive genetic characterization of HP H5N1 AIVs isolated in Sweden during the spring of 2006 is reported. Our data support previous findings on the coincidental spread of multiple sub-lineage H5N1 HPAIVs via migrating aquatic birds to large distance from their origin. The detection of 2.2.1. sub-clade viruses in Sweden adds further data regarding their spread in the North of Europe in 2006. The close genetic relationship of Swedish isolates sub-clade 2.2.2. to the contemporary German and Danish isolates supports the proposition of the introduction and spread of a single variant of 2.2.2. sub-clade H5N1 avian influenza viruses in the Baltic region. The presented findings underline the importance of whole genome analysis.


Subject(s)
Influenza A Virus, H5N1 Subtype/classification , Influenza A Virus, H5N1 Subtype/isolation & purification , Influenza in Birds/virology , Animals , Birds , Cluster Analysis , Genome, Viral , Influenza A Virus, H5N1 Subtype/genetics , Influenza in Birds/epidemiology , Molecular Epidemiology , Molecular Sequence Data , Phylogeny , RNA, Viral/genetics , Sequence Analysis, DNA , Sequence Homology , Sweden/epidemiology , Viral Nonstructural Proteins/genetics , Viral Structural Proteins/genetics
16.
Nat Med ; 14(1): 81-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18157139

ABSTRACT

IL-17A is a T cell-specific cytokine that is involved in chronic inflammations, such as Mycobacterium infection, Crohn's disease, rheumatoid arthritis and multiple sclerosis. Mouse models have explained the molecular basis of IL-17A production and have shown that IL-17A has a positive effect not only on granuloma formation and neurodegeneration through unknown mechanisms, but also on bone resorption through Receptor activator of NF-kappaB ligand (RANKL) induction in osteoblasts. Langerhans cell histiocytosis (LCH) is a rare disease of unknown etiology, lacking an animal model, that cumulates symptoms that are found separately in various IL-17A-related diseases, such as aggressive chronic granuloma formation, bone resorption and soft tissue lesions with occasional neurodegeneration. We examined IL-17A in the context of LCH and found that there were high serum levels of IL-17A during active LCH and unexpected IL-17A synthesis by dendritic cells (DCs), the major cell type in LCH lesions. We also found an IL-17A-dependent pathway for DC fusion, which was highly potentiated by IFN-gamma and led to giant cells expressing three major tissue-destructive enzymes: tartrate resistant acidic phosphatase and matrix metalloproteinases 9 and 12. IFN-gamma expression has been previously documented in LCH and observed in IL-17A-related diseases. Notably, serum IL-17A-dependent fusion activity correlates with LCH activity. Thus, IL-17A and IL-17A-stimulated DCs represent targets that may have clinical value in the treatment of LCH and other IL-17A-related inflammatory disorders.


Subject(s)
Dendritic Cells/metabolism , Histiocytosis, Langerhans-Cell/pathology , Interleukin-17/metabolism , Animals , Arthritis, Rheumatoid/metabolism , Cell Fusion , Humans , Inflammation , Interferon-gamma/metabolism , Lymphocyte Activation , Lymphocytes/metabolism , Mice , Monocytes/metabolism , Mycobacterium/metabolism , Oligonucleotide Array Sequence Analysis
17.
J Virol Methods ; 144(1-2): 27-31, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17482684

ABSTRACT

A screening system including a new real-time PCR assay for the monitoring of influenza A virus in wild birds was developed. The real-time PCR assay uses SYBR green chemistry and the primers are targeting the matrix gene of influenza A virus. The performance of the assay was compared with two other assays, one assay also using SYBR green chemistry and one assay using TaqMan chemistry, i.e. a specific probe. A total of 45 fecal bird samples were analysed for influenza A virus in three different PCR reactions. Overall, 26 samples were positive in at least one of the three real-time PCR assays. Of the 26 samples, 18 were positive by all three reactions. Eight samples were found positive exclusively by the two SYBR green reactions, six of which were detected by both SYBR green reactions. Of the 26 positive samples, 15 samples were verified as positive either by virus isolation or influenza A M2-gene PCR. The results showed that the two SYBR green systems had a higher performance regarding the detection of influenza A as compared to the PCR reaction using a specific probe.


Subject(s)
Animals, Wild/virology , Ducks/virology , Influenza A virus/isolation & purification , Influenza in Birds/diagnosis , Reverse Transcriptase Polymerase Chain Reaction/methods , Animals , Feces/virology , Fluorescent Dyes , Influenza in Birds/virology , RNA, Viral/analysis , Sensitivity and Specificity
18.
Glycobiology ; 17(4): 355-66, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17202152

ABSTRACT

Cell surface carbohydrate structures including sialyl-Lewis X (sLe(x)) and Lewis Y (Le(y)) are important ligands in normal and malignant tissues. The aim here was to determine the possible influence on the expression of such antigens by two viruses varicella-zoster virus (VZV) and cytomegalovirus (CMV) involved in persistent infections of humans. We found that infection of human diploid fibroblasts with both viruses resulted in transcriptional activation of several fucosyltransferase (FUT) genes that were either dormant or expressed at low levels in uninfected cells. Both viruses induced FUT3, FUT5, and FUT6, encoding alpha1,3- and/or alpha1,4-specific fucosyltransferases. CMV, but not VZV, induced transcription of FUT1 (encoding an alpha1,2-specific fucosyltransferase), FUT7, and FUT9. The changes in transcription of FUT genes were expectedly associated with expression of Le(y) in CMV-infected cells and sLe(x) in the VZV-infected fibroblasts although no expression of these antigens was observed in uninfected cells. One major explanation for this difference between CMV- and VZV-infected cells was that CMV, but not VZV, induced expression of FUT1, necessary for Le(y) expression. The induced carbohydrate antigens in CMV- and VZV-infected cells could be of significance for virus spread and possible escape from immune responses.


Subject(s)
Fucosyltransferases/genetics , Gangliosides/genetics , Gene Expression Regulation, Enzymologic , Herpesvirus 3, Human/genetics , Lewis Blood Group Antigens/genetics , CA-19-9 Antigen , Cells, Cultured , Cytomegalovirus/genetics , DNA Primers , Diploidy , Fibroblasts/physiology , Fibroblasts/virology , Humans , Kinetics , Lewis X Antigen , RNA/genetics , Transcription, Genetic , Galactoside 2-alpha-L-fucosyltransferase
19.
Anticancer Res ; 26(5B): 3627-31, 2006.
Article in English | MEDLINE | ID: mdl-17094377

ABSTRACT

BACKGROUND: UV-radiation is the most important causative factor for malignant melanomas of the skin. However, this is not the case for melanomas on sun-sheltered body surfaces. The aim of this study was to investigate if human herpes virus DNA could be found in malignant melanomas in sun-sheltered body areas and if these viruses play a role in the development of extracutaneous melanomas. MATERIALS AND METHODS: Forty-one extracutaneous melanomas were dissected and used for further analysis. Quantitative PCR methods were used for detection of the eight human herpes viruses in melanoma samples. RESULTS: Human herpes virus DNA was absent in 37/41 melanomas, however, cytomegalovirus DNA was detected in two samples, and one sample each exhibited presence of Epstein-Barr virus and Human Herpes virus-6 DNA respectively. CONCLUSION: Human herpes virus DNA is rarely detected in primary malignant melanomas in non-sun exposed body surfaces and is not a major factor for the development of extracutaneous melanomas.


Subject(s)
DNA, Viral/analysis , Herpesvirus 6, Human/isolation & purification , Melanoma/virology , Base Sequence , DNA Primers , Herpesvirus 6, Human/genetics , Humans , Mucous Membrane/virology , Polymerase Chain Reaction , Ultraviolet Rays
20.
J Clin Virol ; 26(3): 301-6, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12637079

ABSTRACT

BACKGROUND: In vitro selection of viruses with decreased drug susceptibility is a useful tool for mapping drug resistance-associated alterations, evaluating cross-resistance profiles, and elucidating molecular mechanisms of antiviral activity. OBJECTIVES: To provide data on mechanisms of selective drug action and features of drug resistance that may be clinically important. STUDY DESIGN: Foscarnet (PFA) and ganciclovir (GCV) were used to induce mutants of the human cytomegalovirus (HCMV) Towne strain. RESULTS: Three new mutations, selected in the presence of PFA, were identified with single base substitutions resulting in T419M, Q578H, and L773V in conserved regions of the HCMV DNA polymerase. None of these mutations have been reported previously. These mutations conferred resistance to PFA but did not change the susceptibility to GCV. A mutant was selected in the presence of GCV. This GCV-selected mutant had no mutation in the UL54 but had an amino acid alteration at codon M460V of UL97, which conferred resistance to GCV. All the mutants had the same growth phenotype as the parental laboratory strain Towne. CONCLUSIONS: We have determined three novel alterations in HCMV DNA polymerase inducing reduced susceptibility to PFA. None of these alterations changed the growth phenotype of the parental virus.


Subject(s)
Cytomegalovirus/drug effects , DNA-Directed DNA Polymerase/genetics , Foscarnet/pharmacology , Genes, Viral/drug effects , Point Mutation , Viral Proteins/genetics , Viral Structural Proteins/genetics , Amino Acid Substitution , Cells, Cultured/virology , Codon/drug effects , Cytomegalovirus/enzymology , Cytomegalovirus/genetics , Cytomegalovirus/growth & development , Drug Resistance, Viral/genetics , Fibroblasts/virology , Ganciclovir/pharmacology , Humans , Lung , Mutation, Missense , Phenotype , Sequence Analysis, Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...